How Much Did XCellR8 Raise?
Funding & Key Investors

XCellR8, a leader in animal-free safety testing, has secured significant capital, with its total funding reaching $140K. The company recently announced a major strategic investment of $140K, underscoring its pivotal role in advancing ethical and regulatory-compliant product testing. This substantial backing positions XCellR8 for continued expansion in the burgeoning market for cruelty-free scientific solutions.

What is XCellR8?

XCellR8
Business ServicesResearch & DevelopmentHealthcare Services

XCellR8 stands as the UK's premier animal-free testing laboratory, distinguished by its nearly two decades of expertise in pioneering human-relevant safety assessments. The company provides Good Laboratory Practice (GLP)-accredited testing methods that are globally recognized by regulatory authorities. Serving a broad spectrum of clients, from emerging startups to established global brands such as Lush and Unilever, XCellR8 offers comprehensive services including safety and claims testing, alongside bespoke solutions. Their mission is to accelerate the worldwide transition to 100% animal-free testing methodologies, ensuring the delivery of reliable data and supporting vegan product claims.

How much funding has XCellR8 raised?

XCellR8 has raised a total of $140K across 1 funding round:

2021

Unspecified

$140K

Unspecified (2021): $140K with participation from Unilever and AstraZeneca

Key Investors in XCellR8

Unilever

Unilever is a multinational consumer goods company with a broad portfolio, known for its commitment to sustainability and ethical sourcing across its diverse range of products.

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines, with a significant presence in the UK.

Undisclosed Investor

An undisclosed investor participating in the funding round, contributing to XCellR8's strategic growth initiatives.

What's next for XCellR8?

With its recent large-scale, late-stage funding, XCellR8 is poised to further solidify its market leadership and accelerate the adoption of its innovative animal-free testing technologies. The strategic investment signals strong confidence in the company's business model and its capacity to meet the escalating global demand for ethical and scientifically robust product evaluation. Future growth is expected to involve expanding service offerings, enhancing technological capabilities, and potentially broadening its international reach to support more brands in their transition to cruelty-free product development and compliance.

See full XCellR8 company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesHuman Resources Management Systems (HRMS)EducationTrainingCommercial PrintingField Service ManagementDocument Management
Business ServicesResearch & Development
Accounting for Legal PracticesBusiness ServicesProject Management
Business ServicesSecurity Information and Event Management (SIEM)

Frequently Asked Questions Regarding XCellR8 Financial Insights

What are the most recent funding rounds that XCellR8 has completed, and what were the funding rounds?
XCellR8 has recently completed 1 funding rounds: Unspecified on Feb 19, 2021.
What is the total amount of funding XCellR8 has raised to date?
XCellR8 has raised a total of $140K in funding to date.
How many funding rounds has XCellR8 completed?
XCellR8 has completed 1 funding rounds.
How much funding did XCellR8 raise in its most recent funding round?
XCellR8 raised $140K in its most recent funding round.
Who are the lead investors in XCellR8's latest funding round?
The lead investor in XCellR8's latest funding round was Unilever. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in XCellR8's history?
The largest funding round in XCellR8's history was $140K.
See more information about XCellR8